clocksoar
Lv61
2290 积分
2021-08-03 加入
-
Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine
2小时前
已完结
-
Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional Etiologies
7小时前
已完结
-
Nasopharyngeal carcinoma
5天前
已完结
-
An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge
22天前
已完结
-
Efficacy, immunogenicity, and safety of a monovalent mRNA vaccine, ABO1020, in adults: A randomized, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
-
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
1个月前
已完结
-
Long‐term immunogenicity and safety of heterologous boosting with a SARS‐CoV‐2 mRNA vaccine (SYS6006) in Chinese participants who had received two or three doses of inactivated vaccine
2个月前
已完结
-
Safety and immunogenicity of heterologous boosting with a bivalent SARS-CoV-2 mRNA vaccine (XBB.1.5/BQ.1) in Chinese participants aged 18 years or more: A randomised, double-blinded, active-controlled phase 1 trial
3个月前
已完结
-
Seroprevalence of varicella-zoster virus in the German population
3个月前
已完结
-
[Application of bridging study design in preventive vaccine clinical trials]
3个月前
已完结